>중동 및 아프리카 만성 질환 관리 시장, 유형별(솔루션 및 서비스), 솔루션 유형(온프레미스 솔루션, 클라우드 기반 솔루션, 웹 기반), 서비스 유형(교육 서비스, 구현 서비스, 컨설팅 서비스 및 기타), 질병 지표(심혈관 질환(CVD), 당뇨병, 만성 폐쇄성 폐 질환(COPD), 관절염, 천식, 암 및 기타), 최종 사용자(의료 서비스 제공자, 의료비 지불자, 기타), 국가(사우디 아라비아, 남아프리카, UAE, 이스라엘, 이집트 및 중동 및 아프리카의 나머지 지역) 산업 동향 및 2028년까지의 예측
시장 분석 및 통찰력: 중동 및 아프리카 만성 질환 관리 시장
만성 질환 관리 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년부터 2028년까지의 예측 기간 동안 13.7%의 CAGR로 성장하고 있으며 2028년까지 5억 9,109만 달러에 도달할 것으로 예상된다고 분석했습니다. 만성 질환의 유병률 증가는 만성 질환 관리 시장의 원동력으로 작용할 것으로 예상됩니다.
만성 질환 관리(CDM)는 만성 건강 상태의 영향을 받는 개인에게 매일 더 잘 관리하는 데 필요한 의료, 지식, 기술 및 리소스를 제공하는 지속적인 관리 및 지원입니다. 주로 다양한 소프트웨어 및 서비스를 통해 제공됩니다. 만성 질환 관리란 통합 관리를 통해 질병의 영향을 예방하거나 최소화하여 만성 질환이 있는 개인의 의료 비용을 줄이고 삶의 질을 개선하는 데 도움이 됩니다.
노령 인구의 증가는 만성 질환 관리 시장을 활성화할 것으로 예상됩니다. 접근성 부족은 만성 질환 관리 시장을 제한할 것으로 예상됩니다. 새로운 기술 발전의 급증은 만성 질환 관리 시장에 기회를 창출할 것으로 예상됩니다. 접근성 부족은 만성 질환 관리 시장에 도전이 될 것으로 예상됩니다.
만성 질환 관리 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 만성 질환 관리 시장 시나리오를 이해하려면 Data Bridge Market Research에 연락하여 분석가 브리핑을 요청하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.
만성 질환 관리 시장 범위 및 시장 규모
만성 질환 관리 시장은 유형, 솔루션 유형, 서비스 유형, 질병 표시 및 최종 사용자를 기준으로 세분화됩니다. 세그먼트 간 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.
- On the basis of type, the chronic disease management market is segmented into solution and services. In 2021, solution segment is expected to dominate the chronic disease management market due to surge in novel technological advancement.
- On the basis of solution type, the chronic disease management market is segmented into on-premise solution, cloud-based solution and web-based. In 2021, on-premise solution segment is expected to dominate the chronic disease management market due to rising strategic initiatives by key players.
- On the basis of service type, the chronic disease management market is segmented into education service, implementation service, consulting service and others. In 2021, implementation services segment is expected to dominate the chronic disease management market due to increasing prevalence of chronic diseases.
- On the basis of disease indication, the chronic disease management market is segmented into cardiovascular diseases (CVD), diabetes, chronic obstructive pulmonary disorders (COPD), arthritis, asthma, cancer and others. In 2021, cardiovascular diseases (CVD) segment is expected to dominate the chronic disease management market due to increased reimbursement policies.
- On the basis of end user, the chronic disease management market is segmented into healthcare providers, healthcare payers and others. In 2021, healthcare providers segment is expected to dominate the chronic disease management market due to rise in awareness regarding the healthcare management service.
Middle East and Africa Chronic Disease Management Market Country Level Analysis
Middle East and Africa chronic disease management market is analyzed and market size information is provided by the country, type, solution type, service type, disease indication and end user as referenced above.
The countries covered in the Middle East and Africa chronic disease management market report are the Saudi Arabia, South Africa, UAE, Israel, Egypt and rest of Middle East and Africa.
Saudi Arabia is expected to dominate the Middle East and Africa chronic disease management market due to the presence of major market players and increased technological advancement in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
만성 질환 관리에 대한 인식을 높이기 위한 주요 시장 참여자들의 전략적 활동이 확대되면서 만성 질환 관리 시장이 활성화되고 있습니다.
만성 질환 관리 시장은 또한 만성 질환 관리 시장에서 모든 국가의 성장에 대한 자세한 시장 분석을 제공합니다. 또한 만성 질환 관리 시장 참여자의 전략과 지리적 입지에 대한 자세한 정보를 제공합니다. 이 데이터는 2010년부터 2019년까지의 과거 기간에 대해 제공됩니다.
경쟁 환경 및 만성 질환 관리 시장 점유율 분석
만성 질환 관리 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선입니다. 위에 제공된 데이터 포인트는 중동 및 아프리카 만성 질환 관리 시장과 관련된 회사의 초점에만 관련이 있습니다.
중동 및 아프리카 만성 질환 관리 시장 보고서를 다루는 주요 기업으로는 Koninklijke Philips NV, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management, LLC, Health Catalyst, ExlServings Holdings, Inc., ScienceSoft USA Corporation, Infosys Limited, IBM Corporation 등이 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.
또한 전 세계 여러 회사에서 많은 계약과 협정을 체결하면서 만성 질환 관리 시장도 가속화되고 있습니다.
예를 들어,
- 2021년 4월, IBM Corporation은 하이브리드 클라우드에서 데이터 접근성과 가용성을 간소화하도록 설계된 고급 스토리지 솔루션을 출시합니다. 모회사인 IBM Corporation이 출시한 이 새로운 솔루션은 회사의 전반적인 시장 수익을 향상시켰습니다.
시장 참여자들의 협력, 제품 출시, 사업 확장, 수상 및 인정, 합작 투자 및 기타 전략을 통해 만성 질환 관리 시장에서 회사의 입지를 강화하고 있으며, 이는 조직의 수익 성장에도 도움이 됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET END USER COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: REGULATIONS
5.1 REGULATION IN THE UNITED STATES:
5.2 GOVERNING REGULATIONS:
5.3 CPT CODES:
5.4 PRACTITIONER ELIGIBILITY:
5.5 PATIENT ELIGIBILITY:
5.6 REQUIREMENTS:
5.7 REGULATIONS IN EUROPE:
5.8 NATIONAL STRATEGY AND LEAD ORGANIZATIONS FOR HEALTHCARE SERVICES IN EUROPE:
5.9 DATA PRIVACY PROTECTION IN EUROPE:
5.1 REGULATIONS IN INDIA:
5.11 RELEVANT ACTS FOR THIS FRAMEWORK:
5.12 DATA PRIVACY PROTECTION IN INDIA:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
6.1.2 GROWING GERIATRIC POPULATION
6.1.3 RISING PER CAPITA INCOME
6.1.4 ADVANCEMENT IN HEALTHCARE INFRASTRUCTURE AND INITIATIVE ACTIVITIES BY GOVERNMENT ORGANIZATION
6.2 RESTRAINTS
6.2.1 HIGH COST OF SERVICES
6.2.2 SECURITY CONCERNS WITH CLOUD-BASED SOLUTIONS
6.3 OPPORTUNITIES
6.3.1 SURGE IN NOVEL TECHNOLOGICAL ADVANCEMENTS
6.3.2 RISING HEALTHCARE EXPENDITURE
6.3.3 INCREASED REIMBURSEMENT POLICIES
6.3.4 RISING DISEASE MANAGEMENT PROGRAMS
6.4 CHALLENGE
6.4.1 LACK OF ACCESSIBILITY
7 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS
7.4 CONCLUSION
8 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE
8.1 OVERVIEW
8.2 SOLUTION
8.3 SERVICES
9 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE
9.1 OVERVIEW
9.2 ON PREMISE SOLUTION
9.3 WEB BASED SOLUTION
9.4 CLOUD BASED SOLUTION
10 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE
10.1 OVERVIEW
10.2 IMPLEMENTATION SERVICES
10.3 CONSULTING SERVICES
10.4 EDUCATION SERVICES
10.5 OTHERS
11 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION
11.1 OVERVIEW
11.2 CARDIOVASCULAR DISEASES (CVD)
11.3 DIABETES
11.4 CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD)
11.5 ASTHMA
11.6 ARTHRITIS
11.7 CANCER
11.8 OTHERS
12 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER
12.1 OVERVIEW
12.2 HEALTHCARE PROVIDERS
12.2.1 HOSPITALS, PHYSICIAN GROUPS, INTEGRATED DELIVERY
12.2.2 DIAGNOSTIC & IMAGING CENTERS
12.2.3 AMBULATORY CARE CENTERS
12.2.4 HOME HEALTHCARE AGENCIES, NURSING HOMES & ASSISTED LIVING FACILITIES
12.2.5 OTHERS
12.3 HEALTHCARE PAYERS
12.3.1 PUBLIC PAYERS
12.3.2 PRIVATE PAYERS
12.4 OTHERS
13 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET BY REGION
13.1 MIDDLE EAST AND AFRICA
13.1.1 SOUTH AFRICA
13.1.2 SAUDI ARABIA
13.1.3 U.A.E.
13.1.4 ISRAEL
13.1.5 EGYPT
13.1.6 REST OF MIDDLE EAST & AFRICA
14 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
15 SWOT ANALYSIS
16 COMPANY PROFILES
16.1 IBM CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 SERVICE PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 KONINKLIJKE PHILIPS N.V.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 COGNIZANT
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 ALLSCRIPTS HEALTHCARE, LLC
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 SOLUTION PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 ALTRUISTA HEALTH
16.5.1 COMPANY SNAPSHOT
16.5.2 SOLUTION PORTFOLIO
16.5.3 RECENT DEVELOPMENTS
16.6 CASENET, LLC
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT & SERVICE PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 CEDAR GATE TECHNOLOGIES
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 CLIEXA, INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 SOLUTION PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 EPIC SYSTEMS CORPORATION
16.9.1 COMPANY SNAPSHOT
16.9.2 SERVICE PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 EXLSERVICE HOLDINGS, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 SERVICE PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 HEALTH CATALYST
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 HINDUJA MIDDLE EAST AND AFRICA SOLUTIONS LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENTS
16.13 INFOSYS LIMITED
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 SOLUTION PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 MEDECISION
16.14.1 COMPANY SNAPSHOT
16.14.2 SOLUTION PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 MINES & ASSOCIATES, INC.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 NXGN MANAGEMENT, LLC
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 PEGASYSTEMS INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 SCIENCESOFT USA CORPORATION
16.18.1 COMPANY SNAPSHOT
16.18.2 INDUSTRY PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 TCS HEALTHCARE TECHNOLOGIES
16.19.1 COMPANY SNAPSHOT
16.19.2 SERVICE PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 VIVIFY HEALTH, INC.
16.20.1 COMPANY SNAPSHOT
16.20.2 SOLUTION PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 WELLSKY
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 ZEOMEGA
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
표 목록
TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)
TABLE 2 NEW CANCER CASES FOR AGE 85+ IN THE U.S.
TABLE 3 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)
TABLE 4 PRICES OF ESSENTIAL CHRONIC DISEASE MANAGEMENT SOLUTIONS
TABLE 5 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA ON PREMISE SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA WEB BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA CLOUD BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA IMPLEMENTATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA CONSULTING SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES (CVD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA DIABETES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA ASTHMA IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA ARTHRITIS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA CANCER IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 39 SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 40 SOUTH AFRICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 41 SOUTH AFRICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 42 SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 43 SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 46 SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 SAUDI ARABIA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 48 SAUDI ARABIA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 49 SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 50 SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 SAUDI ARABIA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 SAUDI ARABIA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 U.A.E. CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 54 U.A.E. SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 55 U.A.E. SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 56 U.A.E. CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 57 U.A.E. CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 58 U.A.E. HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 59 U.A.E. HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 ISRAEL CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 61 ISRAEL SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 62 ISRAEL SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 63 ISRAEL CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 64 ISRAEL CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 65 ISRAEL HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 66 ISRAEL HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 67 EGYPT CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 EGYPT SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 69 EGYPT SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 70 EGYPT CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 71 EGYPT CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 72 EGYPT HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 73 EGYPT HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 74 REST OF MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
그림 목록
FIGURE 1 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 11 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION
FIGURE 12 GROWING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 SOLUTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET
FIGURE 15 PREVALENCE OF CHRONIC DISEASES
FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLIONS)
FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLIONS)
FIGURE 18 EUROPE AGING POPULATION (IN MILLIONS)
FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLIONS)
FIGURE 20 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2020
FIGURE 21 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 22 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 23 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 24 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2020
FIGURE 25 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2019-2028 (USD MILLION)
FIGURE 26 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, CAGR (2021-2028)
FIGURE 27 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, LIFELINE CURVE
FIGURE 28 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2020
FIGURE 29 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2019-2028 (USD MILLION)
FIGURE 30 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, CAGR (2021-2028)
FIGURE 31 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, LIFELINE CURVE
FIGURE 32 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2020
FIGURE 33 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2019-2028 (USD MILLION)
FIGURE 34 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, CAGR (2021-2028)
FIGURE 35 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, LIFELINE CURVE
FIGURE 36 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2020
FIGURE 37 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 38 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 39 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: SNAPSHOT (2020)
FIGURE 41 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020)
FIGURE 42 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 43 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 44 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE (2021-2028)
FIGURE 45 MIDDLE EAST AND AFRICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY SHARE 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
